Cochrane Review: Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease

Zusammenfassung

Schleimlöser im Vergleich zu Placebo bei chronischer Bronchitis oder chronisch obstruktiver Lungenerkrankung - Poole, P - 2019 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001287.pub6/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001287.pub6/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, includin

Kerninformationen

b6/full/de#) [Cochrane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention Collapse all Expand all ## Abstract available in ### Background Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may...

ary objective** • To determine whether treatment with mucolytics reduces exacerbations and/or days of disability in patients with chronic bronchitis or COPD **Secondary objectives** • To assess whether mucolytics lead to improvement in lung function or quality of life • To determine frequency of...

review analysed summary data only, most derived from published studies. For earlier versions, one review author extracted data, which were rechecked in subsequent updates. In later versions, review authors double‐checked extracted data and then entered data into RevMan 5.3 for analysis. ### Main re...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen